Get startedLog in
    Picture of Pure Biologics SA logo

    PUR — Pure Biologics SA Cashflow Statement

    0.000.00%
    pl flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pure Biologics SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    PAS
    PAS
    PAS
    PAS
    PAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-4.55-11.8-11.8-25.6-35.7
    Depreciation
    Non-Cash Items0.184.13.014.767.42
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital8.973.19-18.20.955-0.772
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities5.33-1.35-24-17.4-23.3
    Capital Expenditures-0.162-0.561-0.673-5.76-0.176
    Purchase of Fixed Assets
    Other Investing Cash Flow Items00-27.821.10.567
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-0.162-0.561-28.515.30.391
    Financing Cash Flow Items-0.143-0.349-0.227-0.329-3.11
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities8.55-3.0549.7-1.8824.2
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash13.7-4.96-2.78-3.921.35